Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $4.6 million.

  • Kestra Medical Technologies' Gains from Investment Securities rose 150335.38% to $4.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Gains from Investment Securities is $4.6 million, which was up 150335.38% from $4.5 million recorded in Q3 2025.
  • Kestra Medical Technologies' Gains from Investment Securities' 5-year high stood at $4.6 million during Q4 2025, with a 5-year trough of -$325000.0 in Q4 2024.